Bengaluru, NFAPost: Capgemini announced today its third set of Intelligent Industry offerings: Data Driven Research & Development for Life Sciences. By aligning the expertise of its life science specialists, data scientists and data engineers, Capgemini's latest offer brings the power of Data and Artificial Intelligence (AI) at scale to the research and development (R&D) function. This new set of services will help biopharma companies to improve drug discovery and clinical trials. "Now more than ever there is intense pressure on research and development functions within life sciences to deliver better products more cheaply, quickly and with less risk," comments Franck Greverie, Chief Portfolio Officer at Capgemini and Group Executive Board member. "Artificial intelligence can analyze a broader body of knowledge, clinical data and literature about drugs and conditions at a speed unimaginable for human researchers. Capgemini's new set of Data-Driven R&D for Life Sciences offerings helps to harness the fast-growing set of tools and techniques of digital platforms, modern AI, data science and data engineering to apply them to datasets across a much wider frame of reference than ever before, helping pharmaceutical and biotech companies to reduce the time and cost of getting new therapies to market, and deliver greater personalized therapeutics and patient centricity."

Marc Carrel-Billiard, Managing Director Global Technology R&D, AccentureBangalore: AI can double annual economic growth rates by 2035 by changing the nature of work and spawning a new relationship between man and machine, according to Accenture Research. The impact of AI technologies on business is projected to boost labour productivity by up to 40 percent by fundamentally changing the way work is done and reinforcing people's role to drive growth in business. In an interview with ETCIO, Accenture's Managing Director Global Technology R&D, Marc Carrel-Billiard talks about company's technology labs and its focus areas, new technologies and its impact and key tech trends that CIOs and businesses need to look for and much more. Marc is with Accenture for the past 18 years and currently oversees the Accenture Technology Labs, Accenture Open Innovation, Accenture's global technology R&D organization which explores new and emerging technologies, across seven locations around the world. Which are the key technology domains that you are trying to focus on?